OXYCAL LABORATORIES, INC. – Trademark Portfolio
Entity Type: 03
OXYCAL LABORATORIES, INC. holds 40 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 34 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ESTER-C. The owner is based in PRESCOTT, AZ.
533 MADISON AVENUE
PRESCOTT, AZ 86301
Showing of trademarks Trademarks
Trademark Classifications
OXYCAL LABORATORIES, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does OXYCAL LABORATORIES, INC. have?
OXYCAL LABORATORIES, INC. has 40 U.S. trademarks filed with the USPTO. Of these, 3 registered, 16 abandoned, 21 cancelled.
What trademark classes does OXYCAL LABORATORIES, INC. file in?
OXYCAL LABORATORIES, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are OXYCAL LABORATORIES, INC.'s most well-known trademarks?
OXYCAL LABORATORIES, INC.'s registered trademark portfolio includes well-known marks such as ESTER-C. These are among 3 currently registered trademarks in the portfolio.
What is OXYCAL LABORATORIES, INC.'s trademark registration success rate?
OXYCAL LABORATORIES, INC. has a 8% trademark registration rate, with 3 out of 40 resolved applications resulting in successful registration. Currently, 0 applications are pending review.